Fig. 3From: Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapyBoxplots of five dose-volume criteria for the CTV (a), PTV (b)–(c), bladder (d) and rectum (e) on the planning CT (Ref) and synthetic CT (IGRT, ART1, ART2 and ART3 approaches). Whiskers denote the data within 1.5 times of the interquartile range (IQR) based on 32 plans for the reference and 160 for the four adaptation approaches. Background colors indicate optimal (green), acceptable (yellow) and unacceptable (red) results according to the PACE-C treatment planning guidelineBack to article page